Daniel MacArthur points out that 23andMe seems to be testing people for rare variants associated with Parkinson's disease and he wonders why those results (the company noted recently that it hasn't found anyone with those variations) haven't been reported back to the customers. He's guessing that they are concerned about the reliability of the results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.